018: John Welsh – Giving Weight to Fundamentals & News, Plus the Advantage of Focusing on a Single Sector

Chat With Traders

Kevin Avery

Investing, Education, Business

4.8 • 2.3K Ratings

🗓️ 29 April 2015

⏱️ 39 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This weeks guest is a little different to many of the guests I’ve had on in the past. Instead of giving very little weight to fundamentals and news releases, these two things actually form the foundation for his trading approach. In fact, he almost disregards charts altogether, and he relates the reason for this to his background in accounting and finance. John Welsh has been a full time trader for over 10 years and he’s racked up millions of dollars in profits along the way. His trading consists of both intraday and swing trading, and he concentrates mainly on Biotech stocks, making roughly 90% of his trades within this sector. Now that I’ve given you the 1,000 ft view on John’s trading journey, here he is to fill in the blanks, and give us a lot more depth around his approach. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Chat with traders is sponsored by Trade the Pool.
0:03.6	Our concerns about limited buying power, insufficient capital,
0:07.3	or fear of losing your own money,
0:09.5	preventing you from advancing your trading capabilities.
0:12.4	Trade the Pool is an online stock trading prop firm
0:15.8	that offers funding for stock traders.
0:18.1	Demonstrate your skills, trade their capital,
0:21.0	and keep your profits.
0:22.5	You can engage in intraday trading,
0:24.9	and now swing trading on Trade the Pool.
0:27.8	With any US stock or ETF,
0:30.3	the procedure is straightforward.
0:31.9	Pay in evaluation fee, successfully complete the evaluation,
0:35.9	and get funded.
0:36.8	Visit tradethepool.com forward slash chat to learn more.
0:43.1	GSK believes innovation starts when you stop to listen.
0:47.8	That's why GSK and Veeve Health Care have partnered
0:50.8	with the HIV community for decades,
0:53.6	and developed medicines that better fit the lives of people
0:56.8	living with HIV.
0:58.4	That's just one example of how GSK unites science,
1:02.2	technology, and talent to get ahead of disease together.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Kevin Avery, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Kevin Avery and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.